Results 1 to 10 of about 467,722 (214)

Correction: Grosu et al. New Insights Concerning Phytophotodermatitis Induced by Phototoxic Plants. Life 2024, 14, 1019 [PDF]

open access: yesLife
In the published publication [...]
Cristina Grosu (Dumitrescu)   +8 more
doaj   +2 more sources

Significance of herbal drugs legislation for their rational use [PDF]

open access: yesVojnosanitetski Pregled, 2009
<zakljucak> Kvalitet i bezbednost upotrebe biljnih preparata ostaju i dalje prioritet koji treba zakonski urediti na svetskom nivou. Za registraciju biljnog preparata kao leka postoje isti zahtevi kao i za registraciju drugih lekova u pogledu dokumentacije koja treba da sadrzi predklinicka i klinicka ispitivanja.
Cupara Snežana M.   +1 more
doaj   +4 more sources

Phytochemical and Nutraceutical Screening of Ethanol and Ethyl Acetate Phases of Romanian Galium verum Herba (Rubiaceae)

open access: yesMolecules, 2023
Galium species are used worldwide for their antioxidant, antibacterial, antifungal, and antiparasitic properties. Although this plant has demonstrated its antitumor properties on various types of cancer, its biological activity on cutaneous melanoma has ...
Alexandra-Denisa Semenescu   +8 more
doaj   +1 more source

A Jurisprudential Analysis of Government Intervention and Prenatal Drug Abuse [PDF]

open access: yes, 2002
This article addresses the serious public health problem of substance abuse among pregnant women. Part I of this article introduces the national problem of prenatal drug abuse. Part II discuses the appropriateness of government intervention.
Fortney, Susan Saab
core   +9 more sources

Legislation and drug trials

open access: yesArchives of Disease in Childhood, 1997
Drugs used to treat children are often not licensed for use in this age group. Examples of licensed medicines used outside the conditions of the licence (‘off label’ usage) include the oral administration of a vitamin K injection preparation, and cisapride, which is commonly prescribed for infants, but is not licensed for children under 2 years of age.
B Drumm, D Walsh
openaire   +6 more sources

Artificial Intelligence for Drug Discovery: Are We There Yet? [PDF]

open access: yes, 2023
Drug discovery is adapting to novel technologies such as data science, informatics, and artificial intelligence (AI) to accelerate effective treatment development while reducing costs and animal experiments. AI is transforming drug discovery, as indicated by increasing interest from investors, industrial and academic scientists, and legislators ...
arxiv   +1 more source

Detection of Illicit Drug Trafficking Events on Instagram: A Deep Multimodal Multilabel Learning Approach [PDF]

open access: yes, 2021
Social media such as Instagram and Twitter have become important platforms for marketing and selling illicit drugs. Detection of online illicit drug trafficking has become critical to combat the online trade of illicit drugs. However, the legal status often varies spatially and temporally; even for the same drug, federal and state legislation can have ...
arxiv   +1 more source

Cannabis use prevalence among Baby Boomers before and after implementation of recreational retail sales in California

open access: yesSubstance Abuse Treatment, Prevention, and Policy, 2022
Background As of 2021, 21 US states and territories allowed recreational cannabis use. Although previous research has identified an overall increase in prevalence of cannabis use after legalization, it has been less clear how this change will affect ...
Zachary Carlson   +3 more
doaj   +1 more source

Unrealized potential of drug repositioning in Europe during COVID-19 and beyond: a physician’s perspective

open access: yesJournal of Pharmaceutical Policy and Practice, 2020
Drug repositioning is the scientific strategy of investigating existing drugs for additional clinical indications. The advantages of drug repositioning are that it benefits patients and that it adds new indications to existing drugs for lower costs ...
A. B. Bayoumy   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy